vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $324.4M, roughly 1.5× Revolve Group, Inc.). Revolve Group, Inc. runs the higher net margin — 5.7% vs -10.1%, a 15.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 10.4%). Revolve Group, Inc. produced more free cash flow last quarter ($-13.3M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 9.5%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.
CLOV vs RVLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $324.4M |
| Net Profit | $-49.3M | $18.6M |
| Gross Margin | — | 53.3% |
| Operating Margin | -10.1% | 6.3% |
| Net Margin | -10.1% | 5.7% |
| Revenue YoY | 44.7% | 10.4% |
| Net Profit YoY | -123.2% | 50.4% |
| EPS (diluted) | — | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | $324.4M | ||
| Q3 25 | $496.6M | $295.6M | ||
| Q2 25 | $477.6M | $309.0M | ||
| Q1 25 | $462.3M | $296.7M | ||
| Q4 24 | $337.0M | $293.7M | ||
| Q3 24 | $331.0M | $283.1M | ||
| Q2 24 | $356.3M | $282.5M | ||
| Q1 24 | $346.9M | $270.6M |
| Q4 25 | $-49.3M | $18.6M | ||
| Q3 25 | $-24.4M | $21.2M | ||
| Q2 25 | $-10.6M | $10.2M | ||
| Q1 25 | $-1.3M | $11.8M | ||
| Q4 24 | $-22.1M | $12.3M | ||
| Q3 24 | $-9.2M | $11.0M | ||
| Q2 24 | $7.4M | $15.4M | ||
| Q1 24 | $-19.2M | $10.9M |
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | 24.5% | 51.2% | ||
| Q2 24 | 30.3% | 54.0% | ||
| Q1 24 | 23.6% | 52.3% |
| Q4 25 | -10.1% | 6.3% | ||
| Q3 25 | -4.9% | 7.1% | ||
| Q2 25 | -2.2% | 5.8% | ||
| Q1 25 | -0.3% | 5.0% | ||
| Q4 24 | -6.4% | 3.9% | ||
| Q3 24 | -2.7% | 5.0% | ||
| Q2 24 | 2.0% | 5.8% | ||
| Q1 24 | -6.5% | 3.4% |
| Q4 25 | -10.1% | 5.7% | ||
| Q3 25 | -4.9% | 7.2% | ||
| Q2 25 | -2.2% | 3.3% | ||
| Q1 25 | -0.3% | 4.0% | ||
| Q4 24 | -6.6% | 4.2% | ||
| Q3 24 | -2.8% | 3.9% | ||
| Q2 24 | 2.1% | 5.4% | ||
| Q1 24 | -5.5% | 4.0% |
| Q4 25 | — | $0.27 | ||
| Q3 25 | — | $0.29 | ||
| Q2 25 | — | $0.14 | ||
| Q1 25 | — | $0.16 | ||
| Q4 24 | — | $0.18 | ||
| Q3 24 | — | $0.15 | ||
| Q2 24 | — | $0.21 | ||
| Q1 24 | — | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $292.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $308.7M | $512.5M |
| Total Assets | $541.0M | $765.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $292.3M | ||
| Q3 25 | — | $315.4M | ||
| Q2 25 | — | $310.7M | ||
| Q1 25 | — | $300.8M | ||
| Q4 24 | $194.5M | $256.6M | ||
| Q3 24 | $288.0M | $252.8M | ||
| Q2 24 | $254.8M | $244.7M | ||
| Q1 24 | $208.3M | $273.4M |
| Q4 25 | $308.7M | $512.5M | ||
| Q3 25 | $340.9M | $490.2M | ||
| Q2 25 | $344.2M | $468.6M | ||
| Q1 25 | $336.1M | $453.4M | ||
| Q4 24 | $341.1M | $437.8M | ||
| Q3 24 | $342.2M | $420.8M | ||
| Q2 24 | $324.9M | $405.8M | ||
| Q1 24 | $292.5M | $389.9M |
| Q4 25 | $541.0M | $765.0M | ||
| Q3 25 | $559.7M | $751.3M | ||
| Q2 25 | $575.0M | $722.9M | ||
| Q1 25 | $583.7M | $713.9M | ||
| Q4 24 | $580.7M | $665.5M | ||
| Q3 24 | $653.0M | $670.9M | ||
| Q2 24 | $674.2M | $657.8M | ||
| Q1 24 | $671.8M | $650.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $-10.2M |
| Free Cash FlowOCF − Capex | $-69.0M | $-13.3M |
| FCF MarginFCF / Revenue | -14.1% | -4.1% |
| Capex IntensityCapex / Revenue | 0.4% | 1.0% |
| Cash ConversionOCF / Net Profit | — | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | $48.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | $-10.2M | ||
| Q3 25 | $12.1M | $11.8M | ||
| Q2 25 | $5.4M | $12.6M | ||
| Q1 25 | $-16.3M | $45.1M | ||
| Q4 24 | $34.8M | $3.9M | ||
| Q3 24 | $50.0M | $9.1M | ||
| Q2 24 | $44.8M | $-24.7M | ||
| Q1 24 | $25.9M | $38.4M |
| Q4 25 | $-69.0M | $-13.3M | ||
| Q3 25 | $11.4M | $7.5M | ||
| Q2 25 | $4.8M | $10.4M | ||
| Q1 25 | $-16.5M | $43.4M | ||
| Q4 24 | $33.3M | $2.1M | ||
| Q3 24 | $49.6M | $8.0M | ||
| Q2 24 | $44.4M | $-25.7M | ||
| Q1 24 | $25.5M | $36.7M |
| Q4 25 | -14.1% | -4.1% | ||
| Q3 25 | 2.3% | 2.5% | ||
| Q2 25 | 1.0% | 3.4% | ||
| Q1 25 | -3.6% | 14.6% | ||
| Q4 24 | 9.9% | 0.7% | ||
| Q3 24 | 15.0% | 2.8% | ||
| Q2 24 | 12.5% | -9.1% | ||
| Q1 24 | 7.3% | 13.5% |
| Q4 25 | 0.4% | 1.0% | ||
| Q3 25 | 0.1% | 1.5% | ||
| Q2 25 | 0.1% | 0.7% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.5% | 0.6% | ||
| Q3 24 | 0.1% | 0.4% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 0.6% |
| Q4 25 | — | -0.55× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | 6.04× | -1.60× | ||
| Q1 24 | — | 3.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
